Trial Profile
A prospective, randomised study of seriously injured, shocked adult trauma patients in an urban setting, comparing resuscitation outcomes following administration of an intravenous hemoglobin-based oxygen carrier-201 (HBOC 201) to Normal Saline.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Hemoglobin glutamer (Primary)
- Indications Haemorrhagic shock
- Focus Therapeutic Use
- 02 Jul 2015 New trial record